Global Cancer Pain Market Size, Status and Forecast 2022
This report studies the global Cancer Pain market, analyzes and researches the Cancer Pain development status and forecast in United States, EU, Japan, China, India and Southeast Asia.
This report focuses on the top players in global market, like
This report focuses on the top players in global market, like
- BioDelivery Science
- ProStrakan Group
- Teva pharmaceuticals
- Daiichi Sankyo
- Eli-Lilly
- Galena Biopharma
- Grunenthal Group
- GW Pharmaceuticals
- Hospira
- Johnson & Johnson
- Meda Pharmaceuticals
- Orexo
- Sanofi
- Sorrento Therapeutics
- WEX Pharmaceuticals
- United States
- EU
- Japan
- China
- India
- Southeast Asia
- Immunotherapy
- Hormone therapy
- Opioids
- Non-steroidal anti-inflammatory drugs
- Others
Global Cancer Pain Market Size, Status and Forecast 2022
1 INDUSTRY OVERVIEW OF CANCER PAIN
1.1 Cancer Pain Market Overview
1.1.1 Cancer Pain Product Scope
1.1.2 Market Status and Outlook
1.2 Global Cancer Pain Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Cancer Pain Market by Type
1.3.1 Immunotherapy
1.3.2 Hormone therapy
1.4 Cancer Pain Market by End Users/Application
1.4.1 Opioids
1.4.2 Non-steroidal anti-inflammatory drugs
1.4.3 Others
2 GLOBAL CANCER PAIN COMPETITION ANALYSIS BY PLAYERS
2.1 Cancer Pain Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 COMPANY (TOP PLAYERS) PROFILES
3.1 BioDelivery Science
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Cancer Pain Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 ProStrakan Group
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Cancer Pain Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 Teva pharmaceuticals
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Cancer Pain Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 Daiichi Sankyo
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Cancer Pain Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 Eli-Lilly
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Cancer Pain Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 Galena Biopharma
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Cancer Pain Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 Grunenthal Group
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Cancer Pain Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 GW Pharmaceuticals
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Cancer Pain Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 Hospira
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Cancer Pain Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 Johnson & Johnson
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Cancer Pain Revenue (Value) (2012-2017)
3.10.5 Recent Developments
3.11 Meda Pharmaceuticals
3.12 Orexo
3.13 Sanofi
3.14 Sorrento Therapeutics
3.15 WEX Pharmaceuticals
4 GLOBAL CANCER PAIN MARKET SIZE BY TYPE AND APPLICATION (2012-2017)
4.1 Global Cancer Pain Market Size by Type (2012-2017)
4.2 Global Cancer Pain Market Size by Application (2012-2017)
4.3 Potential Application of Cancer Pain in Future
4.4 Top Consumer/End Users of Cancer Pain
5 UNITED STATES CANCER PAIN DEVELOPMENT STATUS AND OUTLOOK
5.1 United States Cancer Pain Market Size (2012-2017)
5.2 United States Cancer Pain Market Size and Market Share by Players (2016 and 2017)
6 EU CANCER PAIN DEVELOPMENT STATUS AND OUTLOOK
6.1 EU Cancer Pain Market Size (2012-2017)
6.2 EU Cancer Pain Market Size and Market Share by Players (2016 and 2017)
7 JAPAN CANCER PAIN DEVELOPMENT STATUS AND OUTLOOK
7.1 Japan Cancer Pain Market Size (2012-2017)
7.2 Japan Cancer Pain Market Size and Market Share by Players (2016 and 2017)
8 CHINA CANCER PAIN DEVELOPMENT STATUS AND OUTLOOK
8.1 China Cancer Pain Market Size (2012-2017)
8.2 China Cancer Pain Market Size and Market Share by Players (2016 and 2017)
9 INDIA CANCER PAIN DEVELOPMENT STATUS AND OUTLOOK
9.1 India Cancer Pain Market Size (2012-2017)
9.2 India Cancer Pain Market Size and Market Share by Players (2016 and 2017)
10 SOUTHEAST ASIA CANCER PAIN DEVELOPMENT STATUS AND OUTLOOK
10.1 Southeast Asia Cancer Pain Market Size (2012-2017)
10.2 Southeast Asia Cancer Pain Market Size and Market Share by Players (2016 and 2017)
11 MARKET FORECAST BY REGIONS, TYPE AND APPLICATION (2017-2022)
11.1 Global Cancer Pain Market Size (Value) by Regions (2017-2022)
11.1.1 United States Cancer Pain Revenue and Growth Rate (2017-2022)
11.1.2 EU Cancer Pain Revenue and Growth Rate (2017-2022)
11.1.3 Japan Cancer Pain Revenue and Growth Rate (2017-2022)
11.1.4 China Cancer Pain Revenue and Growth Rate (2017-2022)
11.1.5 India Cancer Pain Revenue and Growth Rate (2017-2022)
11.1.6 Southeast Asia Cancer Pain Revenue and Growth Rate (2017-2022)
11.2 Global Cancer Pain Market Size (Value) by Type (2017-2022)
11.3 Global Cancer Pain Market Size by Application (2017-2022)
12 CANCER PAIN MARKET DYNAMICS
12.1 Cancer Pain Market Opportunities
12.2 Cancer Pain Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Cancer Pain Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Cancer Pain Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 MARKET EFFECT FACTORS ANALYSIS
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 RESEARCH FINDING/CONCLUSION
15 APPENDIX
Methodology
Analyst Introduction
Data Source
The report requires updating with new data and is sent in 2-3 business days after order is placed.
1 INDUSTRY OVERVIEW OF CANCER PAIN
1.1 Cancer Pain Market Overview
1.1.1 Cancer Pain Product Scope
1.1.2 Market Status and Outlook
1.2 Global Cancer Pain Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Cancer Pain Market by Type
1.3.1 Immunotherapy
1.3.2 Hormone therapy
1.4 Cancer Pain Market by End Users/Application
1.4.1 Opioids
1.4.2 Non-steroidal anti-inflammatory drugs
1.4.3 Others
2 GLOBAL CANCER PAIN COMPETITION ANALYSIS BY PLAYERS
2.1 Cancer Pain Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 COMPANY (TOP PLAYERS) PROFILES
3.1 BioDelivery Science
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Cancer Pain Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 ProStrakan Group
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Cancer Pain Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 Teva pharmaceuticals
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Cancer Pain Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 Daiichi Sankyo
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Cancer Pain Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 Eli-Lilly
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Cancer Pain Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 Galena Biopharma
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Cancer Pain Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 Grunenthal Group
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Cancer Pain Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 GW Pharmaceuticals
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Cancer Pain Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 Hospira
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Cancer Pain Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 Johnson & Johnson
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Cancer Pain Revenue (Value) (2012-2017)
3.10.5 Recent Developments
3.11 Meda Pharmaceuticals
3.12 Orexo
3.13 Sanofi
3.14 Sorrento Therapeutics
3.15 WEX Pharmaceuticals
4 GLOBAL CANCER PAIN MARKET SIZE BY TYPE AND APPLICATION (2012-2017)
4.1 Global Cancer Pain Market Size by Type (2012-2017)
4.2 Global Cancer Pain Market Size by Application (2012-2017)
4.3 Potential Application of Cancer Pain in Future
4.4 Top Consumer/End Users of Cancer Pain
5 UNITED STATES CANCER PAIN DEVELOPMENT STATUS AND OUTLOOK
5.1 United States Cancer Pain Market Size (2012-2017)
5.2 United States Cancer Pain Market Size and Market Share by Players (2016 and 2017)
6 EU CANCER PAIN DEVELOPMENT STATUS AND OUTLOOK
6.1 EU Cancer Pain Market Size (2012-2017)
6.2 EU Cancer Pain Market Size and Market Share by Players (2016 and 2017)
7 JAPAN CANCER PAIN DEVELOPMENT STATUS AND OUTLOOK
7.1 Japan Cancer Pain Market Size (2012-2017)
7.2 Japan Cancer Pain Market Size and Market Share by Players (2016 and 2017)
8 CHINA CANCER PAIN DEVELOPMENT STATUS AND OUTLOOK
8.1 China Cancer Pain Market Size (2012-2017)
8.2 China Cancer Pain Market Size and Market Share by Players (2016 and 2017)
9 INDIA CANCER PAIN DEVELOPMENT STATUS AND OUTLOOK
9.1 India Cancer Pain Market Size (2012-2017)
9.2 India Cancer Pain Market Size and Market Share by Players (2016 and 2017)
10 SOUTHEAST ASIA CANCER PAIN DEVELOPMENT STATUS AND OUTLOOK
10.1 Southeast Asia Cancer Pain Market Size (2012-2017)
10.2 Southeast Asia Cancer Pain Market Size and Market Share by Players (2016 and 2017)
11 MARKET FORECAST BY REGIONS, TYPE AND APPLICATION (2017-2022)
11.1 Global Cancer Pain Market Size (Value) by Regions (2017-2022)
11.1.1 United States Cancer Pain Revenue and Growth Rate (2017-2022)
11.1.2 EU Cancer Pain Revenue and Growth Rate (2017-2022)
11.1.3 Japan Cancer Pain Revenue and Growth Rate (2017-2022)
11.1.4 China Cancer Pain Revenue and Growth Rate (2017-2022)
11.1.5 India Cancer Pain Revenue and Growth Rate (2017-2022)
11.1.6 Southeast Asia Cancer Pain Revenue and Growth Rate (2017-2022)
11.2 Global Cancer Pain Market Size (Value) by Type (2017-2022)
11.3 Global Cancer Pain Market Size by Application (2017-2022)
12 CANCER PAIN MARKET DYNAMICS
12.1 Cancer Pain Market Opportunities
12.2 Cancer Pain Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Cancer Pain Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Cancer Pain Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 MARKET EFFECT FACTORS ANALYSIS
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 RESEARCH FINDING/CONCLUSION
15 APPENDIX
Methodology
Analyst Introduction
Data Source
The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES
Figure Cancer Pain Product Scope
Figure Global Cancer Pain Market Size (Million USD) (2012-2017)
Table Global Cancer Pain Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Cancer Pain Market Share by Regions in 2016
Figure United States Cancer Pain Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Cancer Pain Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Cancer Pain Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Cancer Pain Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Cancer Pain Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Cancer Pain Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Cancer Pain Market Share by Type in 2016
Figure Immunotherapy Market Size (Million USD) and Growth Rate (2012-2017)
Figure Hormone therapy Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global Cancer Pain Market Share by Application in 2016
Figure Cancer Pain Market Size (Million USD) and Growth Rate in Opioids (2012-2017)
Figure Cancer Pain Market Size (Million USD) and Growth Rate in Non-steroidal anti-inflammatory drugs (2012-2017)
Figure Cancer Pain Market Size (Million USD) and Growth Rate in Others (2012-2017)
Table Cancer Pain Market Size (Million USD) by Players (2016 and 2017)
Figure Cancer Pain Market Size Share by Players in 2016
Figure Cancer Pain Market Size Share by Players in 2017
Table BioDelivery Science Basic Information List
Table Cancer Pain Business Revenue (Million USD) of BioDelivery Science (2012-2017)
Figure BioDelivery Science Cancer Pain Business Revenue Market Share in 2016
Table ProStrakan Group Basic Information List
Table Cancer Pain Business Revenue (Million USD) of ProStrakan Group (2012-2017)
Figure ProStrakan Group Cancer Pain Business Revenue Market Share in 2016
Table Teva pharmaceuticals Basic Information List
Table Cancer Pain Business Revenue (Million USD) of Teva pharmaceuticals (2012-2017)
Figure Teva pharmaceuticals Cancer Pain Business Revenue Market Share in 2016
Table Daiichi Sankyo Basic Information List
Table Cancer Pain Business Revenue (Million USD) of Daiichi Sankyo (2012-2017)
Figure Daiichi Sankyo Cancer Pain Business Revenue Market Share in 2016
Table Eli-Lilly Basic Information List
Table Cancer Pain Business Revenue (Million USD) of Eli-Lilly (2012-2017)
Figure Eli-Lilly Cancer Pain Business Revenue Market Share in 2016
Table Galena Biopharma Basic Information List
Table Cancer Pain Business Revenue (Million USD) of Galena Biopharma (2012-2017)
Figure Galena Biopharma Cancer Pain Business Revenue Market Share in 2016
Table Grunenthal Group Basic Information List
Table Cancer Pain Business Revenue (Million USD) of Grunenthal Group (2012-2017)
Figure Grunenthal Group Cancer Pain Business Revenue Market Share in 2016
Table GW Pharmaceuticals Basic Information List
Table Cancer Pain Business Revenue (Million USD) of GW Pharmaceuticals (2012-2017)
Figure GW Pharmaceuticals Cancer Pain Business Revenue Market Share in 2016
Table Hospira Basic Information List
Table Cancer Pain Business Revenue (Million USD) of Hospira (2012-2017)
Figure Hospira Cancer Pain Business Revenue Market Share in 2016
Table Johnson & Johnson Basic Information List
Table Cancer Pain Business Revenue (Million USD) of Johnson & Johnson (2012-2017)
Figure Johnson & Johnson Cancer Pain Business Revenue Market Share in 2016
Table Meda Pharmaceuticals Basic Information List
Table Cancer Pain Business Revenue (Million USD) of Meda Pharmaceuticals (2012-2017)
Figure Meda Pharmaceuticals Cancer Pain Business Revenue Market Share in 2016
Table Orexo Basic Information List
Table Cancer Pain Business Revenue (Million USD) of Orexo (2012-2017)
Figure Orexo Cancer Pain Business Revenue Market Share in 2016
Table Sanofi Basic Information List
Table Cancer Pain Business Revenue (Million USD) of Sanofi (2012-2017)
Figure Sanofi Cancer Pain Business Revenue Market Share in 2016
Table Sorrento Therapeutics Basic Information List
Table Cancer Pain Business Revenue (Million USD) of Sorrento Therapeutics (2012-2017)
Figure Sorrento Therapeutics Cancer Pain Business Revenue Market Share in 2016
Table WEX Pharmaceuticals Basic Information List
Table Cancer Pain Business Revenue (Million USD) of WEX Pharmaceuticals (2012-2017)
Figure WEX Pharmaceuticals Cancer Pain Business Revenue Market Share in 2016
Table Global Cancer Pain Market Size (Million USD) by Type (2012-2017)
Figure Global Cancer Pain Market Size Share by Type in 2012
Figure Global Cancer Pain Market Size Share by Type in 2013
Figure Global Cancer Pain Market Size Share by Type in 2014
Figure Global Cancer Pain Market Size Share by Type in 2015
Figure Global Cancer Pain Market Size Share by Type in 2016
Figure Global Cancer Pain Market Size Share by Type in 2017
Table Global Cancer Pain Market Size (Million USD) by Application (2012-2017)
Figure Global Cancer Pain Market Size (Million USD) by Application in 2012
Figure Global Cancer Pain Market Size (Million USD) by Application in 2013
Figure Global Cancer Pain Market Size (Million USD) by Application in 2014
Figure Global Cancer Pain Market Size (Million USD) by Application in 2015
Figure Global Cancer Pain Market Size (Million USD) by Application in 2016
Figure Global Cancer Pain Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Cancer Pain
Figure United States Cancer Pain Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Cancer Pain Market Size (Million USD) by Players (2012-2017)
Figure United States Cancer Pain Market Size Share by Players in 2016
Figure United States Cancer Pain Market Size Share by Players in 2017
Figure EU Cancer Pain Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Cancer Pain Market Size (Million USD) by Players (2012-2017)
Figure EU Cancer Pain Market Size Share by Players in 2016
Figure EU Cancer Pain Market Size Share by Players in 2017
Figure Japan Cancer Pain Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Cancer Pain Market Size (Million USD) by Players (2012-2017)
Figure Japan Cancer Pain Market Size Share by Players in 2016
Figure Japan Cancer Pain Market Size Share by Players in 2017
Figure China Cancer Pain Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Cancer Pain Market Size (Million USD) by Players (2012-2017)
Figure China Cancer Pain Market Size Share by Players in 2016
Figure China Cancer Pain Market Size Share by Players in 2017
Figure India Cancer Pain Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Cancer Pain Market Size (Million USD) by Players (2012-2017)
Figure India Cancer Pain Market Size Share by Players in 2016
Figure India Cancer Pain Market Size Share by Players in 2017
Figure Southeast Asia Cancer Pain Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Cancer Pain Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Cancer Pain Market Size Share by Players in 2016
Figure Southeast Asia Cancer Pain Market Size Share by Players in 2017
Figure Global Cancer Pain Market Size (Million USD) by Regions (2017-2022)
Table Global Cancer Pain Market Size (Million USD) by Regions (2017-2022)
Figure Global Cancer Pain Market Size Share by Regions in 2017
Figure Global Cancer Pain Market Size Share by Regions in 2022
Figure United States Cancer Pain Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU Cancer Pain Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan Cancer Pain Revenue (Million USD) and Growth Rate (2017-2022)
Figure China Cancer Pain Revenue (Million USD) and Growth Rate (2017-2022)
Figure India Cancer Pain Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia Cancer Pain Revenue (Million USD) and Growth Rate (2017-2022)
Table Global Cancer Pain Market Size (Million USD) by Type (2017-2022)
Figure Global Cancer Pain Market Size Share by Type in 2017
Figure Global Cancer Pain Market Size Share by Type in 2022
Table Global Cancer Pain Market Size (Million USD) by Application (2017-2022)
Figure Global Cancer Pain Market Size (Million USD) by Application in 2017
Figure Global Cancer Pain Market Size (Million USD) by Application in 2022
Figure Cancer Pain Product Scope
Figure Global Cancer Pain Market Size (Million USD) (2012-2017)
Table Global Cancer Pain Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Cancer Pain Market Share by Regions in 2016
Figure United States Cancer Pain Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Cancer Pain Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Cancer Pain Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Cancer Pain Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Cancer Pain Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Cancer Pain Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Cancer Pain Market Share by Type in 2016
Figure Immunotherapy Market Size (Million USD) and Growth Rate (2012-2017)
Figure Hormone therapy Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global Cancer Pain Market Share by Application in 2016
Figure Cancer Pain Market Size (Million USD) and Growth Rate in Opioids (2012-2017)
Figure Cancer Pain Market Size (Million USD) and Growth Rate in Non-steroidal anti-inflammatory drugs (2012-2017)
Figure Cancer Pain Market Size (Million USD) and Growth Rate in Others (2012-2017)
Table Cancer Pain Market Size (Million USD) by Players (2016 and 2017)
Figure Cancer Pain Market Size Share by Players in 2016
Figure Cancer Pain Market Size Share by Players in 2017
Table BioDelivery Science Basic Information List
Table Cancer Pain Business Revenue (Million USD) of BioDelivery Science (2012-2017)
Figure BioDelivery Science Cancer Pain Business Revenue Market Share in 2016
Table ProStrakan Group Basic Information List
Table Cancer Pain Business Revenue (Million USD) of ProStrakan Group (2012-2017)
Figure ProStrakan Group Cancer Pain Business Revenue Market Share in 2016
Table Teva pharmaceuticals Basic Information List
Table Cancer Pain Business Revenue (Million USD) of Teva pharmaceuticals (2012-2017)
Figure Teva pharmaceuticals Cancer Pain Business Revenue Market Share in 2016
Table Daiichi Sankyo Basic Information List
Table Cancer Pain Business Revenue (Million USD) of Daiichi Sankyo (2012-2017)
Figure Daiichi Sankyo Cancer Pain Business Revenue Market Share in 2016
Table Eli-Lilly Basic Information List
Table Cancer Pain Business Revenue (Million USD) of Eli-Lilly (2012-2017)
Figure Eli-Lilly Cancer Pain Business Revenue Market Share in 2016
Table Galena Biopharma Basic Information List
Table Cancer Pain Business Revenue (Million USD) of Galena Biopharma (2012-2017)
Figure Galena Biopharma Cancer Pain Business Revenue Market Share in 2016
Table Grunenthal Group Basic Information List
Table Cancer Pain Business Revenue (Million USD) of Grunenthal Group (2012-2017)
Figure Grunenthal Group Cancer Pain Business Revenue Market Share in 2016
Table GW Pharmaceuticals Basic Information List
Table Cancer Pain Business Revenue (Million USD) of GW Pharmaceuticals (2012-2017)
Figure GW Pharmaceuticals Cancer Pain Business Revenue Market Share in 2016
Table Hospira Basic Information List
Table Cancer Pain Business Revenue (Million USD) of Hospira (2012-2017)
Figure Hospira Cancer Pain Business Revenue Market Share in 2016
Table Johnson & Johnson Basic Information List
Table Cancer Pain Business Revenue (Million USD) of Johnson & Johnson (2012-2017)
Figure Johnson & Johnson Cancer Pain Business Revenue Market Share in 2016
Table Meda Pharmaceuticals Basic Information List
Table Cancer Pain Business Revenue (Million USD) of Meda Pharmaceuticals (2012-2017)
Figure Meda Pharmaceuticals Cancer Pain Business Revenue Market Share in 2016
Table Orexo Basic Information List
Table Cancer Pain Business Revenue (Million USD) of Orexo (2012-2017)
Figure Orexo Cancer Pain Business Revenue Market Share in 2016
Table Sanofi Basic Information List
Table Cancer Pain Business Revenue (Million USD) of Sanofi (2012-2017)
Figure Sanofi Cancer Pain Business Revenue Market Share in 2016
Table Sorrento Therapeutics Basic Information List
Table Cancer Pain Business Revenue (Million USD) of Sorrento Therapeutics (2012-2017)
Figure Sorrento Therapeutics Cancer Pain Business Revenue Market Share in 2016
Table WEX Pharmaceuticals Basic Information List
Table Cancer Pain Business Revenue (Million USD) of WEX Pharmaceuticals (2012-2017)
Figure WEX Pharmaceuticals Cancer Pain Business Revenue Market Share in 2016
Table Global Cancer Pain Market Size (Million USD) by Type (2012-2017)
Figure Global Cancer Pain Market Size Share by Type in 2012
Figure Global Cancer Pain Market Size Share by Type in 2013
Figure Global Cancer Pain Market Size Share by Type in 2014
Figure Global Cancer Pain Market Size Share by Type in 2015
Figure Global Cancer Pain Market Size Share by Type in 2016
Figure Global Cancer Pain Market Size Share by Type in 2017
Table Global Cancer Pain Market Size (Million USD) by Application (2012-2017)
Figure Global Cancer Pain Market Size (Million USD) by Application in 2012
Figure Global Cancer Pain Market Size (Million USD) by Application in 2013
Figure Global Cancer Pain Market Size (Million USD) by Application in 2014
Figure Global Cancer Pain Market Size (Million USD) by Application in 2015
Figure Global Cancer Pain Market Size (Million USD) by Application in 2016
Figure Global Cancer Pain Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Cancer Pain
Figure United States Cancer Pain Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Cancer Pain Market Size (Million USD) by Players (2012-2017)
Figure United States Cancer Pain Market Size Share by Players in 2016
Figure United States Cancer Pain Market Size Share by Players in 2017
Figure EU Cancer Pain Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Cancer Pain Market Size (Million USD) by Players (2012-2017)
Figure EU Cancer Pain Market Size Share by Players in 2016
Figure EU Cancer Pain Market Size Share by Players in 2017
Figure Japan Cancer Pain Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Cancer Pain Market Size (Million USD) by Players (2012-2017)
Figure Japan Cancer Pain Market Size Share by Players in 2016
Figure Japan Cancer Pain Market Size Share by Players in 2017
Figure China Cancer Pain Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Cancer Pain Market Size (Million USD) by Players (2012-2017)
Figure China Cancer Pain Market Size Share by Players in 2016
Figure China Cancer Pain Market Size Share by Players in 2017
Figure India Cancer Pain Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Cancer Pain Market Size (Million USD) by Players (2012-2017)
Figure India Cancer Pain Market Size Share by Players in 2016
Figure India Cancer Pain Market Size Share by Players in 2017
Figure Southeast Asia Cancer Pain Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Cancer Pain Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Cancer Pain Market Size Share by Players in 2016
Figure Southeast Asia Cancer Pain Market Size Share by Players in 2017
Figure Global Cancer Pain Market Size (Million USD) by Regions (2017-2022)
Table Global Cancer Pain Market Size (Million USD) by Regions (2017-2022)
Figure Global Cancer Pain Market Size Share by Regions in 2017
Figure Global Cancer Pain Market Size Share by Regions in 2022
Figure United States Cancer Pain Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU Cancer Pain Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan Cancer Pain Revenue (Million USD) and Growth Rate (2017-2022)
Figure China Cancer Pain Revenue (Million USD) and Growth Rate (2017-2022)
Figure India Cancer Pain Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia Cancer Pain Revenue (Million USD) and Growth Rate (2017-2022)
Table Global Cancer Pain Market Size (Million USD) by Type (2017-2022)
Figure Global Cancer Pain Market Size Share by Type in 2017
Figure Global Cancer Pain Market Size Share by Type in 2022
Table Global Cancer Pain Market Size (Million USD) by Application (2017-2022)
Figure Global Cancer Pain Market Size (Million USD) by Application in 2017
Figure Global Cancer Pain Market Size (Million USD) by Application in 2022
